Pardeep Nijhawan - 04 Aug 2023 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Signature
/s/ Pardeep Nijhawan
Issuer symbol
EDSA
Transactions as of
04 Aug 2023
Net transactions value
$0
Form type
4
Filing time
04 Aug 2023, 16:18:55 UTC
Previous filing
24 Jul 2023
Next filing
12 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Award +99,300 +17% 694,112 04 Aug 2023 Direct F1
holding EDSA Common Shares 2,356,914 04 Aug 2023 Held by Pardeep Nijhawan Medicine Professional Corporation F2
holding EDSA Common Shares 228,262 04 Aug 2023 By The New Nijhawan Family Trust 2015 F3
holding EDSA Common Shares 224,094 04 Aug 2023 Held by The Digestive Health Clinic Inc. F2
holding EDSA Common Shares 371,727 04 Aug 2023 Held by 1968160 Ontario Inc. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted share units ("RSUs"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2022. The number of RSUs was determined by dividing such portion of the cash bonus by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023.
F2 Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.